AXEPTA, containing the active ingredient Atomoxetine, is a prescription medication primarily used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children, adolescents, and adults. Unlike traditional stimulants, AXEPTA is a non-stimulant option that works by selectively inhibiting the reuptake of norepinephrine, thereby helping to improve focus, attention, and impulse control.
Atomoxetine is a selective norepinephrine reuptake inhibitor (NRI) that enhances norepinephrine levels in the brain. This mechanism is believed to help in managing ADHD symptoms by improving concentration and reducing hyperactive and impulsive behavior.
AXEPTA is indicated for the treatment of ADHD in patients aged 6 years and older. It can be used as a part of a comprehensive treatment program that may include psychological, educational, and social measures.
The dosage of AXEPTA is individualized based on the patient's needs and response to treatment. It is typically administered once or twice daily, with or without food. It is important to follow the prescribing physician's instructions and to not exceed the recommended dosage.
Common side effects of AXEPTA may include dry mouth, decreased appetite, fatigue, nausea, and insomnia. Patients are advised to monitor for any severe side effects and report them to their healthcare provider promptly.
Before starting AXEPTA, patients should inform their healthcare provider of any existing medical conditions, especially heart problems, high blood pressure, or a history of mental health issues. It is essential to discuss all medications being taken to avoid potential interactions.
AXEPTA offers a non-stimulant alternative for managing ADHD symptoms, providing an effective option for those who may not respond well to traditional stimulant medications. Always consult a healthcare professional for personalized advice and treatment options.
Prescription Required 
India
